Federico Caligaris‐Cappio

23.4k total citations · 2 hit papers
211 papers, 12.8k citations indexed

About

Federico Caligaris‐Cappio is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Federico Caligaris‐Cappio has authored 211 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Genetics, 111 papers in Immunology and 70 papers in Pathology and Forensic Medicine. Recurrent topics in Federico Caligaris‐Cappio's work include Chronic Lymphocytic Leukemia Research (131 papers), Lymphoma Diagnosis and Treatment (68 papers) and Immunodeficiency and Autoimmune Disorders (62 papers). Federico Caligaris‐Cappio is often cited by papers focused on Chronic Lymphocytic Leukemia Research (131 papers), Lymphoma Diagnosis and Treatment (68 papers) and Immunodeficiency and Autoimmune Disorders (62 papers). Federico Caligaris‐Cappio collaborates with scholars based in Italy, United States and United Kingdom. Federico Caligaris‐Cappio's co-authors include Paolo Ghia, Michael J. Keating, Thomas J. Kipps, Michael Hallek, Emili Montserrat, Daniel Catovsky, Peter Hillmen, Cristina Scielzo, Bruce D. Cheson and Hartmut Döhner and has published in prestigious journals such as The Lancet, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Federico Caligaris‐Cappio

207 papers receiving 12.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

2008 2.2k citations Federico Caligaris‐Cappio, Michael J. Keating et al. Blood profile →
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

2018 971 citations Federico Caligaris‐Cappio, Michael J. Keating et al. Blood profile →

Peers

Countries citing papers authored by Federico Caligaris‐Cappio

Since Specialization

Citations

This map shows the geographic impact of Federico Caligaris‐Cappio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Caligaris‐Cappio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Caligaris‐Cappio more than expected).

Fields of papers citing papers by Federico Caligaris‐Cappio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Caligaris‐Cappio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Caligaris‐Cappio. The network helps show where Federico Caligaris‐Cappio may publish in the future.

Co-authorship network of co-authors of Federico Caligaris‐Cappio

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Caligaris‐Cappio. A scholar is included among the top collaborators of Federico Caligaris‐Cappio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Caligaris‐Cappio. Federico Caligaris‐Cappio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic Leukemia 2019 ·Cancer Immunology Research ·(unknown), Ronghua Zhang, Cristina Ivan, Giovanni Galletti, Karen Clise-Dwyer, Federica Barbaglio, Lydia Scarfò, Miguel Aracil, Christian Klein, William G. Wierda, William Plunkett, Federico Caligaris‐Cappio, Varsha Gandhi, Michael J. Keating, Maria Teresa Sabrina Bertilaccio	38
2	IL1R8 Deficiency Drives Autoimmunity-Associated Lymphoma Development 2019 ·Cancer Immunology Research ·Federica Riva, Maurilio Ponzoni, Domenico Supino, Maria Teresa Sabrina Bertilaccio, Nadia Polentarutti, Matteo Massara, Fabio Pasqualini, Roberta Carriero, A Innocenzi, Achille Anselmo, (unknown), Giorgia Simonetti, Hans‐Joachim Anders, Federico Caligaris‐Cappio, Alberto Mantovani, Marta Muzio, Cecília Garlanda	13
3	Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis 2017 ·Blood ·Francesca Gorini, Laura Azzimonti, Gloria Delfanti, Lydia Scarfò, Cristina Scielzo, Maria Teresa Sabrina Bertilaccio, Pamela Ranghetti, Alessandro Gulino, Claudio Doglioni, Arianna Di Napoli, Miriam Capri, Claudio Franceschi, Federico Caligaris‐Cappio, Paolo Ghia, Matteo Bellone, Paolo Dellabona, Giulia Casorati, Claudia de Lalla	63
4	Pathogen‐specific B‐cell receptors drive chronic lymphocytic leukemia by light‐chain‐dependent cross‐reaction with autoantigens 2017 ·EMBO Molecular Medicine ·Nereida Jiménez de Oya, Marco De Giovanni, Jessica Fioravanti, Rudolf Übelhart, Pietro Di Lucia, Amleto Fiocchi, Stefano Iacovelli, Dimitar G. Efremov, Federico Caligaris‐Cappio, Hassan Jumaa, Paolo Ghia, Luca G. Guidotti, Matteo Iannacone	15
5	Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients 2016 ·Cancer Research ·Mimma Bianco, Anna Maria Gasparri, Barbara Colombo, Flavio Curnis, Stefania Girlanda, Mirco Ponzoni, Maria Teresa Sabrina Bertilaccio, Arianna Calcinotto, Angelina Sacchi, Elisabetta Ferrero, Marina Ferrarini, Marta Chesi, P. Leif Bergsagel, Matteo Bellone, Giovanni Tonon, Fabio Ciceri, Magda Marcatti, Federico Caligaris‐Cappio, Angelo Corti	20
6	INTERIM RESULTS FROM A PHASE IIA STUDY OF THE ANTI-CXCL12 SPIEGELMER OLAPTESED PEGOL (NOX-A12) IN COMBINATION WITH BENDAMUSTINE/RITUXIMAB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA 2014 ·Haematologica ·Michael Steurer, Lydia Scarfò, Marco Montillo, Ann Janssens, Sophie Wildner, Francesca Romana Mauro, Livio Trentin, J. Thaler, Sonja Burgstaller, Anna Kruschinski, (unknown), (unknown), Paolo Ghia, Federico Caligaris‐Cappio, Marco Gobbi	2
7	From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia 2014 ·Journal of Visualized Experiments ·Benedetta Apollonio, Maria Teresa Sabrina Bertilaccio, Umberto Restuccia, Pamela Ranghetti, Federica Barbaglio, Paolo Ghia, Federico Caligaris‐Cappio, Cristina Scielzo	3
8	In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors 2012 ·Clinical Cancer Research ·(unknown), Benedetta Apollonio, Lydia Scarfò, Pamela Ranghetti, Claudia Fazi, Paolo Ghia, Federico Caligaris‐Cappio, Marta Muzio	37
9	TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA 2012 ·Mediterranean Journal of Hematology and Infectious Diseases ·Marta Muzio, (unknown), Federico Caligaris‐Cappio	17
10	Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients 2011 ·Haematologica ·(unknown), Stavroula Ntoufa, Nikos Papakonstantinou, Tasoula Touloumenidou, Nikolaos Laoutaris, Αchilles Anagnostopoulos, Klea Lamnissou, Federico Caligaris‐Cappio, Κώστας Σταματόπουλος, Paolo Ghia, Marta Muzio, Chrysoula Belessi	62
11	Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy 2010 ·European Journal of Cancer ·Armando Santoro, Lorenza Rimassa, Alberto Sobrero, Giovanni Citterio, Francesco Sclafani, Carlo Carnaghi, Anna Pessino, Francesco Caprioni, (unknown), Maria Chiara Tronconi, Giovanna Finocchiaro, (unknown), (unknown), (unknown), (unknown), Catia Traversari, Federico Caligaris‐Cappio, A. Lambiase, Claudio Bordignon	40
12	Chronic lymphocytic leukemia 2009 ·Federico Caligaris‐Cappio	1
13	Autoimmune disorders and lymphoma 2008 ·Annals of Oncology ·Federico Caligaris‐Cappio	4
14	Leukemia-Derived Immature Dendritic Cells Differentiate into Functionally Competent Mature Dendritic Cells That Efficiently Stimulate T Cell Responses 2004 ·The Journal of Immunology ·Alessandro Cignetti, Antonella Vallario, Ilaria Roato, Paola Circosta, Bernardino Allione, Laura Casorzo, Paolo Ghia, Federico Caligaris‐Cappio	47
15	Cellular interactions, immunodeficiency and autoimmunity in CLL 2000 ·PubMed ·Federico Caligaris‐Cappio	4
16	Human myeloma cells express the CD38 ligand CD31 1999 ·British Journal of Haematology ·Antonella Vallario, Marco Chilosi, Fausto Adami, Licia Montagna, Silvia Deaglio, Fabio Malavasi, Federico Caligaris‐Cappio	2
17	Human myeloma cells express the CD38 ligand CD31 1999 ·British Journal of Haematology ·Antonella Vallario, Marco Chilosi, Fausto Adami, Licia Montagna, Silvia Deaglio, Fabio Malavasi, Federico Caligaris‐Cappio	31
18	Fludarabine ability to down‐regulate Bcl‐2 gene product in CD5⁺ leukaemic B cells: in vitro/in vivo correlations 1997 ·British Journal of Haematology ·(unknown), (unknown), A Alfarano, Alessandra Stacchini, Paola Circosta, (unknown), L Bergui, (unknown), Federico Caligaris‐Cappio	19
19	Bone Marrow Microenvironment and the Progression of Multiple Myeloma 1992 ·Leukemia & lymphoma ·Federico Caligaris‐Cappio, (unknown), (unknown), (unknown), Paolo Ghia, Guido Parvis, L Bergui	29
20	MECCANISMI CELLULARI E MOLECOLARI CHE CONDIZIONANO L'ACCUMULO DI CELLULE NEOPLASTICHE RESTING NELLA LEUCEMIA LINFATICA CRONICA A B LINFOCITI (B-LLC) 1991 ·Haematologica ·Federico Caligaris‐Cappio, M Schena, Davide Gottardi, Gianluca Gaïdano, (unknown), Paolo Ghia, L Bergui	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact